Developing Drug Products in an Aging Society
From Concept to Prescribing
Buch in deiner Nähe kaufen
Beschreibung
This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key “aging” markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key “aging” markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
Focuses on drug product development and prescribing for older patients from a multidisciplinary and global perspective Provides practical guidelines for developing drugs for this population Discusses regulatory pathways for medicines for older patients Includes supplementary material: sn.pub/extras
Autor*in
Sven Stegemann
Themen in »Developing Drug Products in an Aging Society«
adherence aging drug development regulations geriatric drug dosage multimorbidity polypills healthcare
Stimmen zu »Developing Drug Products in an Aging Society«
“This book reviews a wide range of topics related to drug development for an aging population … . The intended audience includes practitioners and/or researchers interested in sharing multidisciplinary knowledge, research, and practice expertise to fill existing knowledge gaps in order to improve drug product development for older, very old, multimorbid, and frail individuals.” (Susan K. Romann, Doody's Book Reviews, February, 2017)
()